
    
      The purpose of the study is to describe the natural history of CEP290-related retinal
      degeneration caused by a compound heterozygous or homozygous intron 26 c.2991+1655A>G
      mutation and to better understand the best assessments for evaluation of patients with this
      condition in a future interventional trial. Patients meeting the entry criteria will be
      enrolled in the study. Visits will occur at Screening, Baseline, and Months 3, 6, and 12, for
      a total duration of 1 year.
    
  